Author of

• 29529

  +

  IBS31 - Trial Design and Novel Drug Accessibility (Ticketed Session) (ID 62)

  • Event: WCLC 2019
  • Type: Interactive Breakfast Session
  • Track: Targeted Therapy
  • Presentations: 1
  • Now Available
  • Moderators:
  • Coordinates: 9/10/2019, 07:00 - 08:00, Amsterdam (2011)

  • 29530

    +

    IBS31.01 - Endpoints and Trial Design for Oncogene Addicted NSCLC (Now Available) (ID 3412)

    07:00 - 08:00  |  Presenting Author(s): Stefan Michiels
    • Abstract
    • Presentation
    • Slides

    Abstract
    

    The availability of targeted anticancer drugs or immunotherapies and the relative affordability of genomic analyses has led to a growing expectation that treatments can be chosen based on the molecular biomarkers of their tissue or blood samples. In this talk Dr. Michiels will provide an overview of the endpoints and contemporary clinical trial designs that can be used in the era of stratified medecine.
    

    Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.